Centre for Gene Regulation & Expression, University of Dundee, Dow Street, Dundee DD1 5EH, United Kingdom.
Cold Spring Harb Perspect Biol. 2012 Oct 1;4(10):a012955. doi: 10.1101/cshperspect.a012955.
Only ∼10% of replication origins that are licensed by loading minichromosome maintenance 2-7 (MCM2-7) complexes are normally used, with the majority remaining dormant. If replication fork progression is inhibited, nearby dormant origins initiate to ensure that all of the chromosomal DNA is replicated. At the same time, DNA damage-response kinases are activated, which preferentially suppress the assembly of new replication factories. This diverts initiation events away from completely new areas of the genome toward regions experiencing replicative stress. Mice hypomorphic for MCM2-7, which activate fewer dormant origins in response to replication inhibition, are cancer-prone and are genetically unstable. The licensing checkpoint delays entry into S phase if an insufficient number of origins have been licensed. In contrast, humans with Meier-Gorlin syndrome have mutations in pre-RC proteins and show defects in cell proliferation that may be a consequence of chronic activation of the licensing checkpoint.
只有约 10%的复制起点通过加载微小染色体维持蛋白 2-7 (MCM2-7) 复合物被正常使用,而大部分复制起点处于休眠状态。如果复制叉的延伸受到抑制,附近的休眠复制起点会被激活,以确保所有的染色体 DNA 都被复制。与此同时,DNA 损伤反应激酶被激活,它优先抑制新的复制工厂的组装。这使得起始事件从基因组的全新区域转移到经历复制应激的区域。MCM2-7 功能不全的小鼠,对复制抑制的反应中激活的休眠复制起点较少,易患癌症且遗传不稳定。复制起始检查点会延迟进入 S 期,如果没有足够数量的复制起点被许可。相比之下,患有 Meier-Gorlin 综合征的人类存在前复制复合物蛋白的突变,并且表现出细胞增殖缺陷,这可能是复制起始检查点慢性激活的结果。